NMD | LinkedIn
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Klaus Wilhardt - Corporate identity, Design, Logo/navnetræk og designguides
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
Big deal: NMD flexes series A muscles - Global University Venturing
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
Investors — NMD Pharma
NMD Pharma - Capnova
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
Company Presentation
NMD Pharma A/S | LinkedIn
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
NMD Pharma Information | NMD Pharma Profile
Management — NMD Pharma
NMD Pharma
NMD Pharma | The Org
Erhverv Aarhus - 照片| Facebook
NMD Pharma
NMD Pharma - Inkef capital
Detailed Description | NMD-GPS
